|
|
Other links at Articles > Urology |
| 1. |
Investigational GnRH Blocker Shows Potential for Advanced Prostate Cancer
|
|
|
The investigational gonadotropin-releasing hormone (GnRH) antagonist degarelix is as effective as standard androgen deprivation therapy in men with prostate cancer, according to phase III results announced at the 23rd Annual Meeting of the European Association of Urology (EAU). Reuters Health Information
|
|
|